Copyright
©The Author(s) 2016.
World J Gastroenterol. Aug 14, 2016; 22(30): 6906-6916
Published online Aug 14, 2016. doi: 10.3748/wjg.v22.i30.6906
Published online Aug 14, 2016. doi: 10.3748/wjg.v22.i30.6906
Figure 1 Clinical pathway for treatment of peritoneal carcinomatosis based on diagnostic systems.
PCI: Peritoneal cancer index; CEA: Carcinoembryonic antigen; CA: Carbohydrate antigen; CT: Computed tomography; CRS: Cytoreductive surgery; HIPEC: Hyperthermic intraperitoneal chemotherapy.
- Citation: Li Y, Zhou YF, Liang H, Wang HQ, Hao JH, Zhu ZG, Wan DS, Qin LX, Cui SZ, Ji JF, Xu HM, Wei SZ, Xu HB, Suo T, Yang SJ, Xie CH, Yang XJ, Yang GL. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol 2016; 22(30): 6906-6916
- URL: https://www.wjgnet.com/1007-9327/full/v22/i30/6906.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i30.6906